{
    "clinical_study": {
        "@rank": "30197", 
        "acronym": "ASA", 
        "arm_group": [
            {
                "arm_group_label": "Spinal anesthesia", 
                "arm_group_type": "Experimental", 
                "description": "The drugs used in the spinal injection are: 12 mg bupivacain, 160 ug morfin och klonidin( < 60 years 75 ug, 60 - 85 years old  60 ug and older than 85 years 45 ug)"
            }, 
            {
                "arm_group_label": "Epidural anesthesia", 
                "arm_group_type": "Active Comparator", 
                "description": "Epidural anesthesia patients group gets an epidural catheter at level Th 8- 10 with per- and postoperative infusion with a routine mixture of:  bupivacain 1 mg/ml, fentanyl 1 ug/ml, and adrenalin 1 ug/ml) until termination."
            }
        ], 
        "brief_summary": {
            "textblock": "The study aim to study whether spinal anesthesia (using: bupivacain, morfin och klonidin)\n      can be better than epidural anesthesia during and after open surgery for renal cell\n      carcinoma. Per- and postoperative pain after spinal anesthesia with klonidin can be reduced\n      and, thus, shorten the hospital stay and rehabilitation of the patients."
        }, 
        "brief_title": "Randomized Study of Spinal Anesthesia Compared With Traditional Epidural Anesthesia Concerning Peroperative and Postoperative Pain After Open Nephrectomy in Patients With Renal Cell Carcinoma", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Pre- and Postoperative Analgesia", 
            "Spinal Anesthesia", 
            "Renal Cell Carcinoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Carcinoma, Renal Cell", 
                "Pain, Postoperative"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  all patients in  ASA score I - III, planned to be treated with open radical\n             nephrectomy or nephron-sparing surgery having renal cell carcinoma\n\n        Exclusion Criteria:\n\n          -  patients in ASA score IV-V,\n\n          -  patients with advanced tumour thrombus in vena cava inferior,\n\n          -  patients with high risk for bleeding\n\n          -  patients with previous chronic pain symptoms\n\n          -  patients having drug abuse\n\n          -  patients having cognitive deficiencies or dementia disease\n\n          -  patients with any contraindication of either spinal or epidural anesthesia\n\n          -  patients younger than 18 years and pregnant woman\n\n          -  patients having a weight less than 45 kg or weight over 120 kg"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "110", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 7, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02030717", 
            "org_study_id": "Dnr 151:2010/81099", 
            "secondary_id": "2008-001491-77"
        }, 
        "intervention": [
            {
                "arm_group_label": "Spinal anesthesia", 
                "description": "spinal injection of 12 mg bupivacain,160 ug morfin och klonidin, according to age", 
                "intervention_name": "klonidin", 
                "intervention_type": "Drug", 
                "other_name": "Brand name: Duraclon - FDA Apl No (NDA) 020615."
            }, 
            {
                "arm_group_label": "Epidural anesthesia", 
                "description": "epidural anesthesia:  patients get an continuous infusion of  a solution with bupivacain 1 mg/ml, fentanyl 1 ug/ml and adrenalin 1 ug/ml", 
                "intervention_name": "epidural anesthesia", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Anesthetics"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Spinal anesthesia", 
            "Epidural anesthesia", 
            "Klonidin", 
            "renal cell carcinoma"
        ], 
        "lastchanged_date": "January 7, 2014", 
        "location": {
            "contact": {
                "email": "ola.winso@umu.se", 
                "last_name": "Ola Winso, MD, PhD", 
                "phone": "+46 90 7852466"
            }, 
            "facility": {
                "address": {
                    "city": "Umea", 
                    "country": "Sweden", 
                    "zip": "901 85"
                }, 
                "name": "Umea University Hospital"
            }, 
            "investigator": {
                "last_name": "Borje Ljungberg, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized Study of Spinal Anesthesia Compared With Traditional Epidural Anesthesia Concerning Peroperative and Postoperative Pain After Open Nephrectomy in Patients With Renal Cell Carcinoma", 
        "other_outcome": {
            "description": "the total amount of analgetics used besides the spinal infusion or the epidural infusion used", 
            "measure": "Need of rescue analgetics", 
            "safety_issue": "No", 
            "time_frame": "within the first 15 days after surgery"
        }, 
        "overall_contact": {
            "email": "borje.ljungberg@urologi.umu.se", 
            "last_name": "Borje Ljungberg, MD, PhD", 
            "phone": "+46 90 7851330", 
            "phone_ext": "51330"
        }, 
        "overall_contact_backup": {
            "email": "Mascha.Thurm@vll.se", 
            "last_name": "Mascha Thurm, MD", 
            "phone": "+ 46 70 5494668"
        }, 
        "overall_official": {
            "affiliation": "Umea University", 
            "last_name": "Borje Ljungberg, MD, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Sweden: Medical Products Agency", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Using a number of variables an index of mobilisation has been created; eg pain (10 graded scale), malaise, intravenous substitution, eating in dining room, Walking outside ward room, passage of stool, carrying urinary bladder catheter, can mobilise out of bed without help", 
            "measure": "postoperative mobilisation index", 
            "safety_issue": "No", 
            "time_frame": "within the first 30 days (plus or minus 5 days) after surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02030717"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "time in hospital after surgery until discharge", 
            "measure": "time of hospitalization", 
            "safety_issue": "No", 
            "time_frame": "within the first 15 days after surgery"
        }, 
        "source": "Ume\u00e5 University", 
        "sponsors": {
            "collaborator": {
                "agency": "University Hospital, Ume\u00e5", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Ume\u00e5 University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}